Current Status of Clinical Trials in Kenya


There is a pressing need to reconsider clinical drug development and distribution of medicines in a truly global sense. The majority of people who desperately need medicinal products get only an inadequate portion of all that is manufactured. This paper is an appeal to those in the international drug development arena to include some of the poorest countries in their drug development programs. It is also a challenge to health professionals and regulatory authorities in those countries to upgrade clinical trial proce¬dures in order to meet international standards and to provide other incentives that attract clinical trials from international drug companies. As a case study, the status of clinical research in Kenya is documented, ft is shown that the framework for conducting clinical trials exists. Potential sponsors are challenged to seek out clinical trial opportunities in this region in order to benefit from the impressive number of excellent health research professionals and large pools of drug-free patient populations.

This is a preview of subscription content, access via your institution.


  1. 1.

    Kilama WL. Health challenges in early twenty-first century sub-Saharan Africa; African J Health Sei. 1996,6(1):9–16.

    Google Scholar 

  2. 2.

    The World Factbook—Kenya,

  3. 3.

    Proceedings from the 21st Anniversary Celebration of the Kenya Medical Research Institute. Kenya: KEMRI; 2000.

Download references

Author information



Corresponding author

Correspondence to Ebi Kimanani PhD.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kimanani, E. Current Status of Clinical Trials in Kenya. Ther Innov Regul Sci 36, 31–39 (2002).

Download citation

Key Words

  • Global drug development
  • Kenya
  • International Conference on Harmonization Good Clinical Practice
  • Africa